The Journal of Practical Medicine >

2024 , Vol. 40 >Issue 18: 2647 - 2653

DOI: https://doi.org/10.3969/j.issn.1006-5725.2024.18.024

Reviews

Research advance on long non⁃coding RNA regulating myeloid⁃derived suppressor cells in tumors

  • Kengjun LUO ,
  • Wenbo ZHANG ,
  • Pengcheng. JIANG
Expand
  • Department of General Surgery，People′s Hospital Affiliated to Jiangsu University，Zhenjiang 212002，China

Received date: 2024-03-31

  Online published: 2024-09-30

Fold

Abstract

Long non-coding RNAs （lncRNAs）， a group of non-coding RNAs with lengths exceeding 200 nucleotides， play a crucial role in the human transcriptome， particularly in various types of cancers， where they are pivotal in regulating the tumor immune microenvironment and tumor cell immune evasion.However， there is currently a lack of systematic literature review. Myeloid-derived suppressor cells （MDSCs）， a subset of myeloid cells with immunosuppressive functions， play a significant role in cancer by directly and indirectly suppressing T cell activity， promoting the expansion of regulatory T cells， modulating the tumor microenvironment， and facilitating tumor metastasis. This review emphasizes the importance of in-depth investigation into the regulatory mechanisms of MDSCs for the discovery of effective tumor therapeutic targets and the development of novel treatment strategies. With further understanding and research into the relationship between lncRNAs and MDSCs， it is anticipated that more targets and new therapeutic approaches will be identified for cancer treatment， thereby improving clinical outcomes for patients.

Key words： lncRNA; MDSCs; tumor; TME; tumor immunity

Cite this article

Kengjun LUO , Wenbo ZHANG , Pengcheng. JIANG . Research advance on long non⁃coding RNA regulating myeloid⁃derived suppressor cells in tumors[J]. The Journal of Practical Medicine, 2024 , 40(18) : 2647 -2653 . DOI: 10.3969/j.issn.1006-5725.2024.18.024

References

1 XIA C F， DONG X S， LI H， et al. Cancer statistics in China and United States， 2022： Profiles， trends， and determinants ［J］. Chin Med J （Engl）， 2022，135（5）：584-590. doi:10.1097/cm9.0000000000002108
2 FENG R M， ZONG Y N， CAO S M， et al. Current cancer situation in China： good or bad news from the 2018 Global Cancer Statistics？ ［J］. Cancer Commun （Lond）， 2019， 39（1）： 22. doi:10.1186/s40880-019-0368-6
3 WANG T， WANG J， JIANG H， et al. Targeted regulation of tumor microenvironment through the inhibition of MDSCs by curcumin loaded self-assembled nano-filaments ［J］. Mater Today Bio， 2022， 15： 100304. doi:10.1016/j.mtbio.2022.100304
4 GHAFOURI-FARD S， MOHAMMAD-RAHIMI H， TAHERI M. The role of long non-coding RNAs in the pathogenesis of thyroid cancer ［J］. Exp Mol Pathol， 2020， 112： 104332. doi:10.1016/j.yexmp.2019.104332
5 LIU Y， HAN Y， ZHANG Y， et al. LncRNAs has been identified as regulators of Myeloid-derived suppressor cells in lung cancer ［J］. Front Immunol， 2023， 14： 1067520. doi:10.3389/fimmu.2023.1067520
6 XIE C， LI S Y， FANG J H， et al. Functional long non-coding RNAs in hepatocellular carcinoma ［J］. Cancer Lett， 2021， 500： 281-291. doi:10.1016/j.canlet.2020.10.042
7 ZHAN D T， XIAN H C. Exploring the regulatory role of lncRNA in cancer immunity ［J］. Front Oncol， 2023， 13： 1191913. doi:10.3389/fonc.2023.1191913
8 ERBER J， HERNDLER-BRANDSTETTER D. Regulation of T cell differentiation and function by long noncoding RNAs in homeostasis and cancer ［J］. Front Immunol， 2023， 14： 1181499. doi:10.3389/fimmu.2023.1181499
9 李悄， 李国政， 张博， 等. 长链非编码RNA MALAT1在肿瘤诊治中的研究进展 ［J］. 实用医学杂志， 2021， 37（16）： 2164-2167. doi:10.3969/j.issn.1006-5725.2021.16.027
10 ZHOU Q， TANG X， TIAN X， et al. LncRNA MALAT1 negatively regulates MDSCs in patients with lung cancer ［J］. J Cancer， 2018， 9（14）： 2436-2442. doi:10.7150/jca.24796
11 VEGLIA F， PEREGO M， GABRILOVICH D. Myeloid-derived suppressor cells coming of age ［J］. Nat Immunol， 2018， 19（2）： 108-119. doi:10.1038/s41590-017-0022-x
12 DONG P， YAN Y， FAN Y， et al. The Role of Myeloid-Derived Suppressor Cells in the Treatment of Pancreatic Cancer ［J］. Technol Cancer Res Treat， 2022， 21： 15330338221142472. doi:10.1177/15330338221142472
13 SIEMI?SKA I， BARAN J. Myeloid-Derived Suppressor Cells as Key Players and Promising Therapy Targets in Prostate Cancer ［J］. Front Oncol， 2022， 12： 862416. doi:10.3389/fonc.2022.862416
14 OSTRAND-ROSENBERG S， LAMB T J， Here PAWELEC G.， There， and Everywhere ： Myeloid-Derived Suppressor Cells in Immunology ［J］. J Immunol， 2023， 210（9）： 1183-1197. doi:10.4049/jimmunol.2200914
15 LV J， ZHAO Y， ZONG H， et al. Increased Levels of Circulating Monocytic- and Early-Stage Myeloid-Derived Suppressor Cells （MDSC） in Acute Myeloid Leukemia ［J］. Clin Lab， 2021， 67（3）. doi:10.7754/clin.lab.2020.200719
16 SAYYADIOSKOIE S R， SCHWACHA M G. Myeloid-Derived Suppressor Cells （MDSCs） and the Immunoinflammatory Response to Injury （Mini Review） ［J］. Shock， 2021， 56（5）： 658-666. doi:10.1097/shk.0000000000001795
17 HOFER F， DI SARIO G， MUSIU C， et al. A Complex Metabolic Network Confers Immunosuppressive Functions to Myeloid-Derived Suppressor Cells （MDSCs） within the Tumour Microenvironment ［J］. Cells， 2021， 10（10）：2700. doi:10.3390/cells10102700
18 OSTRAND-ROSENBERG S， SINHA P， BEURY D W， et al. Cross-talk between myeloid-derived suppressor cells （MDSC）， macrophages， and dendritic cells enhances tumor-induced immune suppression ［J］. Semin Cancer Biol， 2012， 22（4）： 275-281. doi:10.1016/j.semcancer.2012.01.011
19 DAVOODZADEH GHOLAMI M， KARDAR G A， SAEEDI Y， et al. Exhaustion of T lymphocytes in the tumor microenvironment： Significance and effective mechanisms ［J］. Cell Immunol， 2017， 322： 1-14. doi:10.1016/j.cellimm.2017.10.002
20 LIU H， ZENG X， REN X， et al. Targeting tumour-intrinsic N（7）- methylguanosine tRNA modification inhibits MDSC recruitment and improves anti-PD-1 efficacy ［J］. Gut， 2023， 72（8）： 1555-1567. doi:10.1136/gutjnl-2022-327230
21 HACK S P， ZHU A X， WANG Y. Augmenting Anticancer Immunity Through Combined Targeting of Angiogenic and PD-1/PD-L1 Pathways： Challenges and Opportunities ［J］. Front Immunol， 2020， 11： 598877. doi:10.3389/fimmu.2020.598877
22 SHANG W， TANG Z， GAO Y， et al. LncRNA RNCR3 promotes Chop expression by sponging miR-185-5p during MDSC differentiation ［J］. Oncotarget， 2017， 8（67）： 111754-111769. doi:10.18632/oncotarget.22906
23 TIAN D， YU Y， ZHANG L， et al. 23-hydroxybetulinic acid reduces tumorigenesis， metastasis and immunosuppression in a mouse model of hepatocellular carcinoma via disruption of the MAPK signaling pathway ［J］. Anticancer Drugs， 2022， 33（9）： 815-825. doi:10.1097/cad.0000000000001325
24 LI J， SHU X， XU J， et al. S100A9-CXCL12 activation in BRCA1-mutant breast cancer promotes an immunosuppressive microenvironment associated with resistance to immunotherapy ［J］. Nat Commun， 2022， 13（1）： 1481. doi:10.1038/s41467-022-29151-5
25 SUNG H， FERLAY J， SIEGEL R L， et al. Global Cancer Statistics 2020： GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries ［J］. CA Cancer J Clin， 2021， 71（3）： 209-249. doi:10.3322/caac.21660
26 WEN J， XUAN B， GAO Y， et al. Lnc-17Rik promotes the immunosuppressive function of Myeloid-Derived suppressive cells in esophageal cancer ［J］. Cell Immunol， 2023， 385： 104676. doi:10.1016/j.cellimm.2023.104676
27 SMYTH E C， NILSSON M， GRABSCH H I， et al. Gastric cancer ［J］. Lancet， 2020， 396（10251）： 635-648. doi:10.1016/s0140-6736(20)31288-5
28 ZHENG Y， TIAN X， WANG T， et al. Long noncoding RNA Pvt1 regulates the immunosuppression activity of granulocytic myeloid-derived suppressor cells in tumor-bearing mice ［J］. Mol Cancer， 2019， 18（1）： 61. doi:10.1186/s12943-019-0978-2
29 DEKKER E， TANIS P J， VLEUGELS J L A， et al. Colorectal cancer ［J］. Lancet， 2019， 394（10207）： 1467-1480. doi:10.1016/s0140-6736(19)32319-0
30 YU H， CHEN C， HAN F， et al. Long Noncoding RNA MIR4435-2HG Suppresses Colorectal Cancer Initiation and Progression By Reprogramming Neutrophils ［J］. Cancer Immunol Res， 2022， 10（9）： 1095-1110. doi:10.1158/2326-6066.cir-21-1011
31 GAO Y， SHANG W， ZHANG D， et al. Lnc-C/EBPβ Modulates Differentiation of MDSCs Through Downregulating IL4i1 With C/EBPβ LIP and WDR5 ［J］. Front Immunol， 2019， 10： 1661. doi:10.3389/fimmu.2019.01661
32 WANG Y， GAO Y， ZHANG C， et al. Tumor Environment Promotes Lnc57Rik-Mediated Suppressive Function of Myeloid-Derived Suppressor Cells ［J］. J Immunol， 2022， 209（7）： 1401-1413. doi:10.4049/jimmunol.2200195
33 SHANG W， GAO Y， TANG Z， et al. The Pseudogene Olfr29-ps1 Promotes the Suppressive Function and Differentiation of Monocytic MDSCs ［J］. Cancer Immunol Res， 2019， 7（5）： 813-827. doi:10.1158/2326-6066.cir-18-0443
34 FUJISAKA Y， IWATA T， TAMAI K， et al. Long non-coding RNA HOTAIR up-regulates chemokine （C-C motif） ligand 2 and promotes proliferation of macrophages and myeloid-derived suppressor cells in hepatocellular carcinoma cell lines ［J］. Oncol Lett， 2018， 15（1）： 509-514.
35 LI X， LIANG S， FEI M， et al. LncRNA CRNDE Drives the Progression of Hepatocellular Carcinoma by inducing the Immunosuppressive Niche ［J］. Int J Biol Sci， 2024， 20（2）： 718-732. doi:10.7150/ijbs.85471
36 TIAN X， MA J， WANG T， et al. Long non-coding RNA RUNXOR accelerates MDSC-mediated immunosuppression in lung cancer ［J］. BMC Cancer， 2018， 18（1）： 660. doi:10.1186/s12885-018-4564-6
37 LU W， CAO F， FENG L， et al. LncRNA Snhg6 regulates the differentiation of MDSCs by regulating the ubiquitination of EZH2 ［J］. J Hematol Oncol， 2021， 14（1）： 196. doi:10.1186/s13045-021-01212-0
38 TIAN X， ZHENG Y， YIN K， et al. LncRNA AK036396 Inhibits Maturation and Accelerates Immunosuppression of Polymorphonuclear Myeloid-Derived Suppressor Cells by Enhancing the Stability of Ficolin B ［J］. Cancer Immunol Res， 2020， 8（4）： 565-577. doi:10.1158/2326-6066.cir-19-0595
39 TIAN X， MA J， WANG T， et al. Long Non-Coding RNA HOXA Transcript Antisense RNA Myeloid-Specific 1-HOXA1 Axis Downregulates the Immunosuppressive Activity of Myeloid-Derived Suppressor Cells in Lung Cancer ［J］. Front Immunol， 2018， 9： 473. doi:10.3389/fimmu.2018.00473
40 ADEWUNMI O， SHEN Y， ZHANG X H， et al. Targeted Inhibition of lncRNA Malat1 Alters the Tumor Immune Microenvironment in Preclinical Syngeneic Mouse Models of Triple-Negative Breast Cancer ［J］. Cancer Immunol Res， 2023， 11（11）： 1462-1479. doi:10.1158/2326-6066.cir-23-0045
41 GAO Y， WANG T， LI Y， et al. Lnc-chop Promotes Immunosuppressive Function of Myeloid-Derived Suppressor Cells in Tumor and Inflammatory Environments ［J］. J Immunol， 2018， 200（8）： 2603-2614. doi:10.4049/jimmunol.1701721
42 MA X， SHENG S， WU J， et al. LncRNAs as an intermediate in HPV16 promoting myeloid-derived suppressor cell recruitment of head and neck squamous cell carcinoma ［J］. Oncotarget， 2017， 8（26）： 42061-42075. doi:10.18632/oncotarget.14939
43 LI Y， ZHANG Q， WU M， et al. Suppressing MDSC Infiltration in Tumor Microenvironment Serves as an Option for Treating Ovarian Cancer Metastasis ［J］. Int J Biol Sci， 2022， 18（9）： 3697-3713. doi:10.7150/ijbs.70013
Options
Outlines

/

〈 〉